Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,470.28 +3,277.76 (+5.54%) CMC Crypto 200
1,363.86 +86.88 (+6.80%)
Siemens Healthineers AG (0PMJ.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
At close: 05:39PM BST
| Previous close | 51.36 |
| Open | 51.40 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 51.40 - 52.32 |
| 52-week range | 44.38 - 58.10 |
| Volume | |
| Avg. volume | 464,590 |
| Market cap | 517.847M |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 0.31 |
| EPS (TTM) | 1.69 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Interested In Siemens Healthineers' (ETR:SHL) Upcoming €0.95 Dividend? You Have Four Days Left
It looks like Siemens Healthineers AG ( ETR:SHL ) is about to go ex-dividend in the next 4 days. The ex-dividend date...
- Simply Wall St.
Investing in Siemens Healthineers (ETR:SHL) five years ago would have delivered you a 57% gain
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
Business WireSiemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
TARRYTOWN, N.Y., July 20, 2023--The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer1 for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. Labs operating at low to medium testing volumes will benefit from competitive advantages that the analyzer offers, including improved turnaround time predictability, advanced reporting functionality, and focused safety
© 2024 Yahoo. All rights reserved.